4//SEC Filing
HOLLIS EDEN PHARMACEUTICALS INC /DE/ 4
Accession 0001181431-07-008920
$HRBRCIK 0000899394operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:00 PM ET
Size
13.8 KB
Accession
0001181431-07-008920
Insider Transaction Report
Form 4
WEBER ROBERT W
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2007-02-05$2.25/sh+3,000$6,750→ 25,490 total - Sale
Common Stock
2007-02-05$5.40/sh−1,200$6,480→ 23,990 total - Exercise/Conversion
Stock Option (Right to Buy)
2007-02-05−3,000→ 0 totalExercise: $2.25Exp: 2008-02-26→ Common Stock (3,000 underlying) - Sale
Common Stock
2007-02-05$5.39/sh−300$1,617→ 25,190 total
Holdings
- 3,500(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on November 3, 2006.
- [F2]Includes 308 shares of the Issuer's common stock acquired by the reporting person under the Issuer's 401(k) Plan between July 31, 2006 and December 31, 2006. The information in this report is based on a plan statement dated as of December 31, 2006.
- [F3]The option was fully exercisable beginning February 26, 2003.
Documents
Issuer
HOLLIS EDEN PHARMACEUTICALS INC /DE/
CIK 0000899394
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899394
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 6:00 PM ET
- Size
- 13.8 KB